4DMedical Renews University of Michigan Medical Center Contract Until June 2028, Shares Jump 4%

MT Newswires Live
Jul 18, 2025

4DMedical (ASX:4DX) said it renewed its contract with the University of Michigan Medical Center for another three years from July 1 to June 30, 2028, for a total value of around AU$155,000, according to a Friday Australian bourse filing.

University of Michigan clinicians and researchers will have access to 4DMedical's full suite of structural lung analysis applications via the Enterprise Core Computing platform.

The firm also reported the award of AU$1.1 million in non-dilutive cash funding under the first round of Australia's Economic Accelerator Innovate grant program for a project led by the University of Adelaide with 4DMedical as one of the partners.

The project will seek to develop AI-derived functional biomarkers to enhance respiratory disease diagnosis and treatment.

Its shares jumped 4% in recent trading on Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10